Brain insulin study aims to unlock antipsychotic side effects
NCT ID NCT07109245
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the antipsychotic medication haloperidol may block insulin action in the brain, which could explain why these drugs often cause weight gain and diabetes. Researchers will give healthy volunteers either haloperidol or a placebo and use brain scans to measure changes. The goal is to understand the mechanism so future treatments can be safer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INSULIN SENSITIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Addiction and Mental Health
RECRUITINGToronto, Ontario, M6J 1H3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Voice-Based app map healthy brain aging across 80 years?
- Brain waves under pressure: can light uncover the signature of mental work?
- Olive oil compound plus creatine: a new edge for body and mind?
- Can one avocado a day sharpen the aging brain?
- Could a himalayan pepper sharpen your gaming edge?
- Soy power: could natural compounds sharpen your mind?